What is the mechanism of masked megaloblastic anemia in a person who has donated blood every three months for 1.5 years?

Masked Megaloblastic Anemia in Frequent Blood Donors

In a person donating blood every 3 months for 1.5 years, "masked" megaloblastic anemia occurs when concurrent iron deficiency from repeated blood donations suppresses the characteristic macrocytosis (elevated MCV) that would normally reveal underlying B12 or folate deficiency, resulting in a normocytic or even microcytic anemia despite megaloblastic changes in the bone marrow.

Mechanism of Masking

The masking phenomenon operates through competing effects on red blood cell size:

• Iron deficiency from repeated phlebotomy produces microcytic red cells (small RBCs)
• B12/folate deficiency produces macrocytic red cells (large RBCs)
• The net result is a falsely "normalized" MCV (typically 80-99 fL) that conceals the megaloblastic process 1

Each whole blood donation removes approximately 200-250 mg of iron. With donations every 3 months over 1.5 years (6 donations total), cumulative iron loss reaches 1,200-1,500 mg—enough to deplete iron stores and cause iron deficiency anemia in most donors, particularly premenopausal women or those with marginal iron intake.

Why This Matters Clinically

The danger of masked megaloblastic anemia is delayed diagnosis. Without the typical macrocytosis "red flag," clinicians may attribute the anemia solely to iron deficiency and miss the underlying B12/folate deficiency, which can cause irreversible neurological damage if untreated 2.

Diagnostic Clues Despite Normal MCV

Even when MCV appears normal, several laboratory parameters reveal the underlying megaloblastic process 1:

• Hemoglobin <10 g/dL with disproportionate severity
• RDW ≥16% (reflecting mixed cell populations—both microcytic and macrocytic cells)
• Reticulocyte index ≤2% (inappropriately low for degree of anemia)
• Elevated indirect bilirubin (from ineffective erythropoiesis)
• Thrombocytopenia or low-normal platelets (megaloblastic changes affect all cell lines)

The combination of hemoglobin <10 g/dL, MCV 80-99 fL, RDW ≥16%, and reticulocyte index ≤2% carries a 58% probability of masked megaloblastic anemia 1.

Critical Diagnostic Step

Peripheral blood smear examination is essential and non-negotiable 1, 3. Even with normal MCV, the smear will show:

• Hypersegmented neutrophils (≥5% with ≥5 lobes, or any with ≥6 lobes)—the most reliable morphologic marker
• Macro-ovalocytes (large oval red cells)
• Anisocytosis and poikilocytosis (size and shape variation)

An additional automated parameter, elevated neutrophil myeloperoxidase index (MPXI), can identify masked megaloblastic anemia when measured on certain hematology analyzers, regardless of MCV 4.

Pathophysiology in Blood Donors

The dual deficiency develops through:

1. Iron depletion: Direct loss through repeated phlebotomy
2. Folate depletion: Accelerated erythropoiesis attempting to compensate for blood loss increases folate consumption beyond dietary intake
3. Possible B12 depletion: Though less common, increased cell turnover may unmask marginal B12 stores

The guideline evidence notes that folate supplementation/fortification can mask B12 deficiency-induced megaloblastic anemia, particularly in older adults 2. In blood donors, the reverse occurs—iron deficiency masks the megaloblastic picture.

Clinical Pitfall to Avoid

Do not treat with iron supplementation alone without checking B12 and folate levels first. Correcting iron deficiency will unmask the macrocytosis, but more importantly, untreated B12 deficiency can progress to subacute combined degeneration of the spinal cord even while hematologic parameters improve with iron alone.

Recommended Diagnostic Algorithm

For any frequent blood donor presenting with anemia:

1. Order complete iron studies (ferritin, iron, TIBC, transferrin saturation)
2. Simultaneously measure B12 and folate levels—do not wait for iron studies to return
3. Review peripheral smear for hypersegmented neutrophils regardless of MCV
4. Check RDW, reticulocyte count, LDH, and indirect bilirubin as additional clues
5. If B12 is low-normal (<300 pg/mL) with clinical suspicion, add methylmalonic acid and homocysteine for confirmation

Treat both deficiencies concurrently—iron replacement AND B12/folate supplementation as indicated by laboratory results.